# A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions

> **NCT01499771** · PHASE1 · COMPLETED · sponsor: **Ranbaxy Laboratories Limited** · enrollment: 80 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT01499771
- **Lead sponsor:** Ranbaxy Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2009-10
- **Final completion:** 2009-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2012-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01499771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01499771, "A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01499771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*